Overview

Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake

Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
0
Participant gender:
All
Summary
The investigators are trying to determine if a single dose of Ticagrelor will increase delivery of intraarterially-infused adenosine into the forearm interstitium, consistent with adenosine reuptake blockade.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Vanderbilt University
Treatments:
Adenosine
Dipyridamole
Ticagrelor
Criteria
Inclusion Criteria:

1. Subjects will be healthy volunteers, without significant pulmonary, cardiovascular
gastrointestinal, hematological or renal diseases

2. Not taking any regular medications

3. Able to provide signed consent prior to study participation.

Exclusion Criteria:

1. History of asthma

2. Pregnancy

3. Exposure to an investigational drug in the last 2 months.

4. Known hypersensitivity to study medications